Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I)

Author(s): Mohammad Amjad Kamal, Md. Asaduzzaman Khan

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 41 , 2020


Become EABM
Become Reviewer
Call for Editor

[1]
Rahman MH, Akter R, Behl T, et al. COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy. Curr Pharm Des 2020; 26(41): 5224-40.
[2]
Shawon J, Akter Z, Hossen MM, et al. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism. Curr Pharm Des 2020; 26(41): 5241-60.
[3]
Wilkin P, Al-Yozbaki M, George A, Gupta GK, Wilson C. The Undiscovered Potential of Essential Oils for Treating SARS-CoV-2 (COVID-19). Curr Pharm Des 2020; 26(41): 5261-77.
[4]
Pamuru RR, Ponneri N, Damu AG, Vadde R. Targeting Natural Products for the Treatment of COVID-19 – An Updated Review. Curr Pharm Des 2020; 26(41): 5278-85.
[5]
Sohrab SS, Suhail M, Kamal MA, Ahmad F, Azhar EI. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2. Curr Pharm Des 2020; 26(41): 5286-92.
[6]
Warsi MK, Kamal MA, Baeshen MN, Izhari MA, Firoz A, Mobashir M. Comparative Study of Gene Expression Profiling Unravels Functions Associated with Pathogenesis of Dengue Infection. Curr Pharm Des 2020; 26(41): 5293-9.
[7]
Dhasmana A, Kashyap VK, Dhasmana S, et al. Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi-layered High Throughput Virtual Screening Approach. Curr Pharm Des 2020; 26(41): 5300-9.


free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 41
Year: 2020
Published on: 26 November, 2020
Page: [5221 - 5223]
Pages: 3
DOI: 10.2174/138161282641201126124050

Article Metrics

PDF: 32
HTML: 1